Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Crinetics Pharmaceuticals, Inc. (CRNX)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 39.6 | 41.2 | | 30.9 | 62.3 | 145.5 | 200.7 | 161.5 |
| Short-term investments | 167.8 | 209.1 | | | | | | 31.8 |
| Other current assets | 77.4 | 55.2 | | 347.4 | 354.0 | 182.7 | 144.0 | 10.6 |
| Total current assets | 284.8 | 305.4 | | 378.3 | 416.3 | 328.2 | 344.7 | 204.0 |
| Property, plant, and equipment, net | 3.2 | 3.3 | | 3.6 | 3.2 | 2.7 | 2.8 | 2.9 |
| Other fixed assets | 2.0 | 2.0 | | | | | | |
| Total assets | 293.3 | 314.0 | | 384.9 | 421.7 | 333.3 | 351.0 | 209.4 |
| |
| Accounts payable | 4.8 | 5.9 | | 5.9 | 9.0 | | 3.4 | |
| Accrued expenses | | | | | | | | 5.4 |
| Short-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 27.8 | 20.4 | | 18.7 | 17.1 | 20.3 | 12.6 | 7.1 |
| Total current liabilities | 32.6 | 26.3 | | 24.6 | 26.1 | 20.3 | 16.0 | 12.4 |
| Other liabilities | 6.5 | 7.4 | | 9.0 | 9.5 | 10.0 | 3.1 | 3.3 |
| Total liabilities | 39.1 | 33.7 | | 33.5 | 35.6 | 30.2 | 19.1 | 15.8 |
| |
| Shareholders' equity [+] | 254.1 | 280.3 | | 351.4 | 386.2 | 303.0 | 331.9 | 193.6 |
| Retained earnings | -536.1 | -485.2 | | -394.2 | -352.3 | -309.9 | -275.3 | -244.5 |
| Tangible shareholders' equity | 254.1 | 280.3 | | 351.4 | 386.2 | 303.0 | 331.9 | 193.6 |
|